✦ LIBER ✦

Surrogate markers in antiangiogenesis clinical trials

✍ Scribed by Davis, D W; McConkey, D J; Abbruzzese, J L; Herbst, R S

Book ID: 109997623
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 249 KB
Volume: 89
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate markers in clinical trials—Cha

Surrogate markers in clinical trials—Challenges and opportunities

✍ Raphaël Duivenvoorden; Eric de Groot; Erik S.G. Stroes; John J.P. Kastelein 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Surrogate endpoints in clinical trials

✍ Lawrence Friedman; Salim Yusuf 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Validation of Surrogate Markers in Multi

Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements

✍ Ariel Alonso; Helena Geys; Geert Molenberghs; Michael G. Kenward; Tony Vangeneug 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Biopsies as surrogate marker for clinica

Biopsies as surrogate marker for clinical trials using immunotherapy

✍ L. Håkansson; B. Gustafsson; M. Bernsen; A. Håkansson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Biomarkers and surrogate endpoints in cl

Biomarkers and surrogate endpoints in clinical trials

✍ Thomas R. Fleming; John H. Powers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Surrogate endpoints in randomized cardio

Surrogate endpoints in randomized cardiovascular clinical trials

✍ Michael Domanski; Stuart Pocock; Corine Bernaud; Jeffrey Borer; Nancy Geller; Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB